John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 20,000 shares at $30.20 ($594K) on 2014-10-08, disclosed to the SEC on 2014-10-09.
Scheduled sale ($594k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.22 | 10,000 | $292K | 49.2% |
| 2 | $30.20 | 10,000 | $302K | 50.8% |
| Total | $29.71 avg | 20,000 | $594K | 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |